Schimke immuno-osseous dysplasia: case report and review of 25 patients

Autor Saraiva, J., Dinis, A., Resende, C., Faria, E., Gomes, C., Correia, A, Gil, J., da Fonseca, N.
Vydáno 1999

Alemtuzumab as graft-versus-host disease (GVHD) prophylaxis strategy in a developing country: lower rate of acute GVHD, increased risk of cytomegalovirus reactivation

Autor Resende, C.B., Rezende, B.M., Bernardes, P.T.T., Teixeira, G.M., Teixeira, M.M., Pinho, V., Bittencourt, H.
Vydáno v Braz J Med Biol Res (2017)

Geographic spread of epidemic multiresistant Staphylococcus aureus clone in Brazil.

Autor Teixeira, L A, Resende, C A, Ormonde, L R, Rosenbaum, R, Figueiredo, A M, de Lencastre, H, Tomasz, A
Vydáno 1995

Neutrophil activity in sepsis: a systematic review

Autor Resende, C.B., Borges, I., Gonçalves, W.A., Carneiro, R., Rezende, B.M., Pinho, V., Nobre, V., Teixeira, M.M.
Vydáno v Braz J Med Biol Res (2020)

Caspase-1 is active since the early phase of rheumatoid arthritis

Autor Mourão A F, Raquel H, Navalho M, Rodrigues A M, Canhão H, Polido-Pereira J, Cascão R, Resende C, Fonseca J E, Moita L F
Vydáno 2010-11-01

Caspase-1 is active since the early phase of rheumatoid arthritis

Autor Cascão, R, Polido-Pereira, J, Canhão, H, Rodrigues, A M, Navalho, M, Raquel, H, Mourão, A F, Resende, C, Fonseca, J E, Moita, L F
Vydáno 2010

Predictors of chronicity and the discriminative value of the new ACR/EULAR rheumatoid arthritis classification criteria in an untreated polyarthritis cohort with less than 6 weeks...

Autor Mourão, A F, Canhão, H, Moura, R A, Cascão, R, Weinmann, P, Rodrigues, A, Pereira, J, Resende, C, Capela, S, Pereira da Silva, J A, Fonseca, J E
Vydáno 2010

Inflammatory biomarkers in infective endocarditis: machine learning to predict mortality

Autor Ris, T., Teixeira‐Carvalho, A., Coelho, R. Matos Pinto, Brandao‐de‐Resende, C., Gomes, M. Souza, Amaral, L. Rodrigues, Pinto, P. H. Oliveira Murta, Santos, L. J. Souza, Salles, J. Teixeira, Roos‐Hesselink, Jolien, Verkaik, N., Ferrari, T. Cristina Abreu, Nunes, M. C. Pereira
Vydáno v Clin Exp Immunol (2019)